Catalyst Wire Dossier Catalyst Wire Dossier

SHR0302 base gel

SHR0302 · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR0302 base gel, covering 2026-02-18 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo [Phase 2]

See pricing